Company intelligence / Profile preview

Maxitec

Rockville, Maryland, United Statesmaxitec.co.za ↗

Ownership: Private
Employees: ~114
Development stage: Other

Overview

MaxCyte provides industry-leading non‐viral cell engineering platforms used by biopharma partners to enable the development of next-generation cell and gene therapies. Its technologies have supported over 35 clinical trials and contributed to the development of FDA-approved therapies such as CASGEVY® through partnerships with companies like Vertex Pharmaceuticals and CRISPR Therapeutics. The company has signed at least 29 Strategic Platform License agreements with leading developers across diverse therapeutic areas.

Modalities: Cell therapyGene therapyProtein productionNon-viral electroporation platform
Industry: Drug Discovery Services

Partnerships

Vertex PharmaceuticalsCRISPR TherapeuticsAt least 29 Strategic Platform License partnersOri Biotech

Beyond the preview

Go deeper on Maxitec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maxitec.

Explore the full profile